学科与关键词
关键词
SCLC transformationtherapyEGFR mutant adenocarcinoma
- Combination of EGFR-TKIs with Chemotherapy versus EGFR-TKIs alone in EGFR-Mutant Advanced NSCLC with Concomitant Genetic AlterationsFeng, W.; Gu, W.; Zhang, H.; Lu, Y.; Gu, W.; Li, M.; Yang, S.; Zhang, J.; Ye, Z.; Lin, Q.; Liang, Y.; Chen, H.; Cheng, Y.; Yao, M.被引 1
- Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatmentYuman, Yu; Yuehong, Wang; Linying, Wu; Xuanli, Xu; Hua, Zhou; Qing, Wang; Jianying, ZhouMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(5): e23712.
- Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancerZhang, Shi-Ling; Zhang, Chan -Yuan; Chen, Yu-Qing; Li, Yu -Fa; Xie, Zhi; Zhang, Xu-Chao; Zhou, Qing; Zhong, Wen-Zhao; Huang, Jie; Sun, Hao; Zheng, Ming-Ying; Xiao, Fa-Man; Yan, Hong-Hong; Lu, Dan-Xia; Lv, Zhi-Yi; Wu, Yi-Long; Chen, Hua-Jun*; Yang, Jin-Ji*Journal of Thoracic Disease, 2023, 15(9).
